GlassScriptPhysician profile
Haley Anne Spencer
NPI 1194281188
$5,684.76
in general payments reported to CMS, 2019-2025
19 companies · $1,023 in 2025
The $1,023 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $584 · 2022: $1,051 · 2023: $1,518 · 2024: $1,508 · 2025: $1,023.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,989 · Education: $59.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,989.37 |
| Education | $59.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,724.28 | 2021-2025 | Enbrel, Tavneos, Otezla |
| Ucb, INC. | $983.50 | 2021-2025 | Cimzia, Bimzelx, Rystiggo |
| Janssen Biotech, INC. | $600.04 | 2021-2025 | Simponi Aria, Tremfya |
| Mallinckrodt Hospital Products INC. | $460.26 | 2022-2025 | Acthar |
| Abbvie INC. | $432.45 | 2023-2025 | |
| Glaxosmithkline, LLC. | $429.72 | 2021-2024 | Benlysta |
| Genentech USA, INC. | $368.27 | 2021-2025 | Actemra |
| Novartis Pharmaceuticals Corporation | $299.27 | 2023-2025 | |
| Organon LLC | $85.52 | 2023-2025 | Hadlima, Renflexis |
| Horizon Therapeutics Plc | $66.25 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.62 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $40.77 | 2024-2025 | Orencia |
| Lilly USA, LLC | $30.73 | 2024 | Taltz |
| Sobi, INC | $26.90 | 2025 | |
| Lundbeck LLC | $21.98 | 2023 | Vyepti |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $18.22 | 2021 | |
| Alexion Pharmaceuticals, INC. | $17.12 | 2024 | Ultomiris |
| Fresenius Kabi USA, LLC | $13.29 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $12.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haley Spencer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.